Cartesian Therapeutics, Inc. / Fundamentals
Income statement
- Net revenue
€885.48K - Cost of goods sold
€0.00 - Gross profit
€885.48K - SG&A expenses
€25.20M - R&D expenses
€45.09M - EBITDA
-€65.52M - D&A
€2.17M - EBIT
-€75.95M - Interest expenses
€0.00 - EBT
-€31.05M - Tax expenses
€247.69K - Net income
-€31.29M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€29.02M - Changes in working capital
€20.77M - Operating cash flow
-€29.29M - Capex
€9.13M - Other investing cash flow
€302.93K - Net investing cash flow
-€8.82M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€101.19M - Net financing cash flow
€101.24M - Foreign exchange effects
€12.08K - Net change in cash
€63.14M - Cash at end of period
€139.86M - Free cash flow
-€20.17M
Balance sheet
- Cash and cash equivalents
€138.37M - Cash and short-term investments
€138.37M - Total receivables
€305.51K - Inventory
€0.00 - Other current assets
€2.34M - Total current assets
€141.02M - Property, plant & equipment
€15.06M - Goodwill
€41.57M - Intangible assets
€129.97M - Long-term investments
€3.22M - Other non-current assets
€4.79M - Total non-current assets
€194.61M - Total assets
€335.63M - Accounts payable
€391.82K - Short-term debt
€6.54M - Other current liabilities
€3.64M - Total current liabilities
€10.58M - Long-term debt
€8.25M - Deferred tax liabilities
€13.93M - Other non-current liabilities
€305.05M - Total non-current liabilities
€327.23M - Total liabilities
€337.81M - Common stock
€2.59K - Retained earnings
-€598.86M - Other equity
-€3.95M - Total equity
-€2.18M - Total liabilities and shareholders' equity
€335.63M
Company information
- Market capitalization
€236.43M - Employees
66 - Enterprise Value
€103.82M
Company ratios
- Gross margin
-
100.0% - EBITDA margin
-
-7,399.7% - EBIT margin
-
-8,577.6% - EBT margin
-
-3,506.1% - Net margin
-
-3,534.1% - ROE
-
1,434.9% - ROA
-
-9.3% - Asset turnover
-
0.3% - FCF margin
-
-4,338.6% - FCF yield
-16.2% - Efficiency ratio
7,499.7% - Net sales per employee
-
€13.42K - Net income per employee
-
-€474.15K